http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201892383-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201892383-A1 |
| titleOfInvention | COMPOSITION FOR THE TREATMENT OF DIABETES OR DIAZHIRENA, CONTAINING ANALOGUE OF OXYNTHOMODULIN |
| abstract | The present invention relates to a composition for the prevention or treatment of diabetes, diabetes, or diabetic complications, containing an analogue of oxyntomodulin as an active ingredient. The invention also relates to a method of treating diabetes, diabetes, or diabetic complications, comprising administering to the subject a pharmaceutically effective amount of the analogue of oxyntomodulin. The analogue of oxyntomodulin has a high ability to activate the GLP-1 receptor (glucagon-like peptide-1) and the glucagon receptor compared to native oxyntomodulin. Analogue of oxyntomodulin induces the development of beta cells and increases insulin secretion, thereby reducing blood glucose levels, which were increased due to a high-fat, high-fat diet. The analogue of oxyntomodulin induces a decrease in body weight and a decrease in food intake with increased insulin sensitivity and makes it possible to maintain blood glucose levels that are not controlled due to insulin resistance at normal levels. Therefore, an analogue of oxintomodulin can be effectively used to prevent or treat diabetes and related diseases. |
| priorityDate | 2012-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.